<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03938220</url>
  </required_header>
  <id_info>
    <org_study_id>33017/03/19</org_study_id>
    <nct_id>NCT03938220</nct_id>
  </id_info>
  <brief_title>Electrical Cardiometry Compared to Transthoracic Echocardiography in Fluid Responsiveness in Sepsis</brief_title>
  <official_title>Validation of Electrical Cardiometry Measurements Compared to Transthoracic Echocardiography in Fluid Responsiveness in Sepsis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tanta University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Tanta University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to evaluate the diagnostic accuracy of electrical cardiometry (EC)&#xD;
      for the noninvasive determination of fluid responsiveness in sepsis and agreement of (EC)&#xD;
      compared to transthoracic echocardiography (TTE).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Usual investigations [complete blood count (CBC), C reactive protein (CRP), serum&#xD;
      procalcitonin, serum lactate, arterial blood gases (ABG), blood culture, electrocardiogram&#xD;
      (ECG) and liver and renal function tests] will be done.&#xD;
&#xD;
      Once the diagnosis of sepsis is definite and the patient develops hypotension, all patients&#xD;
      will undergo simultaneous measurement by (EC) using the ICON_ device and (TTE).&#xD;
&#xD;
      Electrical cardiometry (EC) measurements: by the ICON_ hemodynamic monitor (ICON&#xD;
      Cardiotronics, Inc., La Jolla, CA 92307; Osyka Medical GmbH, Berlin, and Germany, model C3,&#xD;
      Serial no: 1725303). Four sensors of (EC) will be applied (1st: 5 cm above the base of the&#xD;
      neck, 2nd: on the base of the neck, 3rd: lower thorax at the level of the xiphoid and 4th: 5&#xD;
      cm below the 3rd electrode at the level of the anterior axillary line). The ICON continuously&#xD;
      displays heart rate, stroke volume, and cardiac output.&#xD;
&#xD;
      Transthoracic echocardiography (TTE) measurements: will be performed by using Philips (CX50 -&#xD;
      Extreme edition) equipped with echo probe. SV of the left ventricle will be calculated using&#xD;
      LVOT diameter (D) just below the aortic valve from parasternal long-axis view and velocity&#xD;
      time integral (VTI) measured in left ventricle outflow tract (LVOT) from apical 5 chamber&#xD;
      view (by pulsed wave Doppler), respectively. The machine's built-in software uses the formula&#xD;
      ''(πD2/4) × VTI × HR'' to calculate CO.&#xD;
&#xD;
      Management of sepsis will be done according to surviving sepsis campaign guidelines in 2016&#xD;
      and its update 2018.&#xD;
&#xD;
      Fluid resuscitation will be 30 mL/kg of intravenous infusion of lactated ringer to be given&#xD;
      within the first 3 h (≈5 mL/kg/30 min) guided by fluid responsiveness (fluid responder if SV&#xD;
      increases by &gt; 10% after the fluid challenge). If the patient becomes fluid non-responder,&#xD;
      vasopressor infusion (norepinephrine 0.05-0.3µg/kg/min) will start. The end of the study is&#xD;
      when mean arterial blood pressure &gt; 65 mmHg (either by fluid or both fluid and vasopressor).&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 1, 2019</start_date>
  <completion_date type="Anticipated">September 10, 2021</completion_date>
  <primary_completion_date type="Anticipated">September 10, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Diagnostic accuracy of electrical cardiometry to predict fluid responsiveness.</measure>
    <time_frame>24 hours</time_frame>
    <description>Fluid resuscitation will be 30 mL/kg of intravenous infusion of lactated ringer to be given within the first 3 h (≈5 mL/kg/30 min) guided by fluid responsiveness (fluid responder if stroke volume increases by &gt; 10% after the fluid challenge). If the patient becomes fluid non-responder, vasopressor infusion (norepinephrine 0.05-0.3µg/kg/min) will start. The end of the study is when mean arterial blood pressure&gt; 65 mmHg (either by fluid or both fluid and vasopressor).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Agreement of electrical cardiometry with transthoracic echocardiography in the change of stroke volume before and after fluid challenge.</measure>
    <time_frame>24 hours</time_frame>
    <description>Fluid resuscitation will be 30 mL/kg of intravenous infusion of lactated ringer to be given within the first 3 h (≈5 mL/kg/30 min) guided by fluid responsiveness (fluid responder if stroke volume increases by &gt; 10% after the fluid challenge). If the patient becomes fluid non-responder, vasopressor infusion (norepinephrine 0.05-0.3µg/kg/min) will start. The end of the study is when mean arterial blood pressure&gt; 65 mmHg (either by fluid or both fluid and vasopressor).</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">25</enrollment>
  <condition>Electrical Cardiometry</condition>
  <condition>Transthoracic Echocardiography</condition>
  <condition>Fluid Responsiveness</condition>
  <condition>Sepsis</condition>
  <condition>Stoke Volume</condition>
  <arm_group>
    <arm_group_label>fluid responders</arm_group_label>
    <description>fluid responder if stroke volume increases by &gt; 10% after the fluid challenge</description>
  </arm_group>
  <arm_group>
    <arm_group_label>fluid non responders</arm_group_label>
    <description>fluid responder if stroke volume increases by &lt;= 10% after the fluid challenge</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Electrical Cardiometry</intervention_name>
    <description>Electrical cardiometry (EC) measurements: by the ICON_ hemodynamic monitor (ICON Cardiotronics, Inc., La Jolla, CA 92307; Osyka Medical GmbH, Berlin, and Germany, model C3, Serial no: 1725303). Four sensors of EC will be applied (1st: 5 cm above the base of the neck, 2nd: on the base of neck, 3rd: lower thorax at the level of the xiphoid and 4th: 5 cm below the 3rd electrode at the level of anterior axillary line). The ICON continuously displays HR, SV and CO.</description>
    <arm_group_label>fluid non responders</arm_group_label>
    <arm_group_label>fluid responders</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        This prospective cohort study will be carried out in Tanta University Hospitals at surgical&#xD;
        ICU&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age from 19 to 65 years old.&#xD;
&#xD;
          -  Clinical criteria of sepsis [acute change in sepsis-related organ failure assessment&#xD;
             (SOFA) variables ≥ 2 points consequent to the infection which include: PaO2/FiO2 ratio&#xD;
             &lt; 300, Glasgow Coma Scale score &lt; 15, mean arterial pressure (MAP) &lt; 70 mmHg, serum&#xD;
             creatinine &gt;1.2 mg/dl or urine output &lt; 0.5 ml/kg/h, serum bilirubin &gt; 1.2 mg/dL,&#xD;
             platelet count &lt; 150 X 103 /µl].&#xD;
&#xD;
          -  Developing hypotension (mean arterial blood pressure ≤ 65 mmHg).&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Other causes of shock&#xD;
&#xD;
          -  Previous cardiac disease&#xD;
&#xD;
          -  Rhythm other than sinus rhythm or heart rate &gt; 140 beats/min&#xD;
&#xD;
          -  Chronic renal failure.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
  </eligibility>
  <overall_contact>
    <last_name>Mohammed Said ElSharkawy, Master</last_name>
    <phone>+201021559948</phone>
    <email>mselsharkawy@med.tanta.edu.eg</email>
  </overall_contact>
  <location>
    <facility>
      <name>Tanta University Hospitals</name>
      <address>
        <city>Tanta</city>
        <state>ElGharbiaa</state>
        <zip>31511</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mohammed Said ElSharkawy</last_name>
      <phone>00201021559948</phone>
      <email>mselsharkawy@med.tanta.edu.eg</email>
    </contact>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>April 30, 2019</study_first_submitted>
  <study_first_submitted_qc>May 1, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">May 6, 2019</study_first_posted>
  <last_update_submitted>September 9, 2021</last_update_submitted>
  <last_update_submitted_qc>September 9, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 10, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Tanta University</investigator_affiliation>
    <investigator_full_name>Mohammed Said ElSharkawy</investigator_full_name>
    <investigator_title>Assistant lecturer</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sepsis</mesh_term>
    <mesh_term>Toxemia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

